Media covers CCM's virtual showcases
The showcase must — and will — go on for UC acting, musical theatre students, thanks to CCM alums
The University of Cincinnati's College-Conservatory of Music pioneered the idea of creating a showcase of graduating musical theatre seniors to get them in front of key industry agents and casting directors in New York City. Senior acting students similarly present an annual showcase for industry insiders in New York and Los Angeles. The showcases became a model for programs across the country, but this year coronavirus canceled the events.
Thanks to the help of some CCM alumni, new Virtual Senior Showcases will allow industry professionals and the general public to see this year’s graduating student performers in action.
The news was covered by Broadway World, Local 12 and WVXU.
Featured image at top: A student performs at CCM's Moveable Feast. Photo/Andrew Higley/UC Creative + Brand
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.